Partnering with Zambon
A modern multinational company with ambitious growth projects
We are a modern multinational chemical-pharmaceutical company founded on the history and values of an innovative Italian family-owned enterprise with ambitious growth and development projects.
Today we are present in 84 countries on 5 continents.
Our partners share with us the same aspiration: taking care of people's health by continuing to innovate.
Our expertise in the business development
We have subsidiaries across Western Europe, though our know-how and experience also extend to markets such as China, Russia, Brazil and Colombia, where we have a direct presence.
Our capabilities
Market access and regulatory know-how
We actively cooperate with the European Medicines Agency (EMA) and with European national regulatory authorities, with the FDA in the US, the ANVISA in Brazil, and the CFDA in China. We have in-depth knowledge of regulatory and Market Access matters in 20 countries.
Commercial and marketing excellence
We are present in Western Europe, Russia, Brazil and China, specializing in the Central Nervous System, Respiratory Health and Rare Diseases.
Manufacturing excellence
Four manufacturing plants approved by EMA, FDA, ANVISA, SWISSMEDIC and Chinese FDA producing high quality finished products, as well as a Virtual Plant handling over 80 Contract Manufacturing Organizations throughout the world.
Devices
We use medical devices and cutting-edge technologies to optimize the administration of inhalation drugs as well as to develop Home Care assistance and support programs for patients.
Why partner with Zambon
Added values for a potential partner to choose Zambon are:
- Private, family owned company
- Fast decision taking
- Long term commitment
- Consolidated experience in partner relationships
- More than a century of experience in the pharmaceutical industry
- A capillary commercial presence in Europe, Russia, Brazil and China
What we have to offer
We constantly evaluate new partnering opportunities for our entire portfolio for countries where our products are currently not marketed.
We work side by side with our partners so that we can maximize business opportunities together, pursuing goals in an efficient, effective, balanced and timely manner.
Zambon is committed to collaborating with a broad range of pharmaceutical and biotech companies from all over the world
Events
Severe Respiratory Diseases
- Bio International Convention - June 4-7, 2018 Boston
- European Cystic Fibrosis conference – June 6-9 2018 – Belgrade
- Bio Pharma America - September 5–6, 2018 Boston
- North American CF conference - October 18-20, 2018 · Denver
- Bio Europe - November 5–7, 2018 Copenhagen
- World Orphan Drug Congress - 6th–8th November 2018 Barcelona
Cough and cold
- Bio International Convention - June 4-7, 2018 Boston
- European Cystic Fibrosis conference – June 6-9 2018 – Belgrade
- Bio Pharma America - September 5–6, 2018 Boston
- ERS – 15-19 September 2018, Paris
- North American CF conference - October 18-20, 2018 - Denver
- Bio Europe - November 5–7, 2018 Copenhagen
Parkinson’s Disease
- Bio International Convention - June 4-7, 2018 Boston
- European Academy of Neurology – June 16-19, 2018 Lisbona
- Bio Pharma America - September 5–6, 2018 Boston
- Movement Disorder Society - October 5-9, 2018, Hong Kong
- Bio Europe - November 5–7, 2018 Copenhagen
Device
- European Cystic Fibrosis conference – June 6-9 2018 – Belgrade
- ERS – 15-19 September 2018, Paris
- DDL - Dec 2018, Edinburgh
